HEMO Hemogenyx Pharmaceuticals share price with HEMO chart and fundamentals

Hemogenyx Pharmaceuticals (HEMO)
Share Price

Details Today

2.30 -1.29 % -0.03
High / Low 2.40 2.18
Vol / Time 68,150,826 16:30

Search Share Prices

Hemogenyx Pharmaceuticals Plc is a biotechnology company developing novel therapies to transform bone marrow and blood stem cell transplantation, announces the readmission of its enlarged issued share capital to the standard listing segment of the Official List and to trading on the main market for listed securities of the London Stock Exchange. The Company is the holding company for Hemogenyx LLC, a US-based biotechnology company developing therapies to transform bone marrow and blood stem cell transplantation. These therapies will replace the need for existing methods of preparation of patients for a transplantation such as chemotherapy and radiation treatments, and will address the problem of finding a matching stem cell donor and reduce the risk of blood stem cell rejection after transplantation.

Trend Direction

1 Day 1 Week 1 Month
Top Volume Pharmaceuticals & Biotechnology Shares %Chng
Sareum Holdings -3.87%
Gunsynd -3.28%
Midatech Pharma 38.18%
Valirx 23.94%
GlaxoSmithKline -0.01%
Avacta Group 1.81%
Nuformix 0.00%
Evgen Pharma -5.19%
SkinBioTherapeutics 5.60%
AstraZeneca -0.25%
View all sectors
Hemogenyx Pharmaceuticals - (HEMO) share price history
Date Open High Low Close Volume
17/06/2021 2.40 2.40 2.18 2.30 68,150,826
16/06/2021 2.59 2.69 2.33 2.33 82,035,472
15/06/2021 2.11 2.63 2.11 2.55 139,131,338
14/06/2021 2.08 2.15 2.00 2.10 18,043,316
11/06/2021 1.98 2.10 1.92 2.08 36,826,905
More Hemogenyx Pharmaceuticals History
Data for Hemogenyx Pharmaceuticals is end of day only and updates after midnight GMT. Data is gathered from historic databases such as Quandl and other reliable sources, however errors do occur. Please use for information purposes only.